| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 10269 | 2018 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to … C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ... JAMA oncology 3 (4), 524-548, 2017 | 8372 | 2017 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 7923 | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 4241 | 2018 |
| Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 MG Griswold, N Fullman, C Hawley, N Arian, SRM Zimsen, HD Tymeson, ... The Lancet 392 (10152), 1015-1035, 2018 | 3211 | 2018 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1492 | 2022 |
| Elective versus therapeutic neck dissection in node-negative oral cancer AK D’Cruz, R Vaish, N Kapre, M Dandekar, S Gupta, R Hawaldar, ... New England Journal of Medicine 373 (6), 521-529, 2015 | 1271 | 2015 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 1064 | 2018 |
| Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global … N Fullman, J Yearwood, SM Abay, C Abbafati, F Abd-Allah, J Abdela, ... The Lancet 391 (10136), 2236-2271, 2018 | 855 | 2018 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … Global Burden of Disease Cancer Collaboration JAMA oncology, 2019 | 641 | 2019 |
| Challenges to effective cancer control in China, India, and Russia PE Goss, K Strasser-Weippl, BL Lee-Bychkovsky, L Fan, J Li, ... The lancet oncology 15 (5), 489-538, 2014 | 586 | 2014 |
| Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic … R Lozano, N Fullman, D Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 2091-2138, 2018 | 549 | 2018 |
| Harmful effects of nicotine A Mishra, P Chaturvedi, S Datta, S Sinukumar, P Joshi, A Garg Indian Journal of Medical and Paediatric Oncology 36 (01), 24-31, 2015 | 511 | 2015 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 449 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 436 | 2024 |
| The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016 D Prabhakaran, P Jeemon, M Sharma, GA Roth, C Johnson, ... The Lancet Global Health 6 (12), e1339-e1351, 2018 | 398 | 2018 |
| Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial T Gupta, JP Agarwal, S Jain, R Phurailatpam, S Kannan, S Ghosh-Laskar, ... Radiotherapy and Oncology 104 (3), 343-348, 2012 | 387 | 2012 |
| Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial V Noronha, A Joshi, VM Patil, J Agarwal, S Ghosh-Laskar, A Budrukkar, ... Journal of Clinical Oncology 36 (11), 1064-1072, 2018 | 349 | 2018 |
| A review of the systemic adverse effects of areca nut or betel nut A Garg, P Chaturvedi, PC Gupta Indian journal of medical and paediatric oncology 35 (01), 3-9, 2014 | 328 | 2014 |
| Head and neck cancers in developing countries P Joshi, S Dutta, P Chaturvedi, S Nair Rambam Maimonides medical journal 5 (2), 2014 | 295 | 2014 |
Prathamesh PaiConsultant Head Neck Surgeon, Punyashlok Ahilyadevi Holkar Head & Neck Cancer Institute of IndiaEmail verificata su hncii.com